after ex parte appeal
on 04 Dec 2004
Last Applicant/ Owned by
P. Fach 1016
Schaffhausen
CH
CH-8201
Serial Number
78186213 filed on 18th Nov 2002
Registration Number
N/A
Correspondent Address
Myron Cohen
Filing Basis
No Filing Basis
Disclaimer
NO DATA
MEDICAL APPARATUS FOR TREATING DERMATOLOGICAL DISEASES AND CONDITIONS, INFLAMMATORY DISEASES AND CONDITIONS, AND LONG TERM CHRONIC DISEASES AND CONDITIONS BY PHOTO DYNAMIC THERAPY,NAMELY, MEDICAL STIMULATION DEVICES HAVING A LASER AND/OR SEMICONDUCTOR DIODES FOR EMITTING LIGHT RADIATION TO ACTIVATE LIGHT-ACTIVATABLE SUBSTANCES ABSORBED INTO TISSUE AND AN ELECTROMAGNETIC WAVE RADIATOR FOR CONCURRENRead More
MEDICAL LIGHT ACTIVATED AND LIGHT MODIFYING SUBSTANCES USEFUL TN PHOTO DYNAMIC THERAPY, NAMELY, PHOTOFRIN, 5-AMINOLEVULANACID, HEMATOPORPHYRIN, VERTEPORFIN, CHLORTNS, PHTHALDODYANJNES,PHENOTHIAZINE, BENZOPORPHYRTN-DERIVATIVE MONO ACID-A (A TMPn), L-PHENYLALANIN AND PLENOSOL
MEDICAL APPARATUS FOR TREATING DERMATOLOGICAL DISEASES AND CONDITIONS, INFLAMMATORY DISEASES AND CONDITIONS, AND LONG TERM CHRONIC DISEASES AND CONDITIONS BY PHOTO DYNAMIC THERAPY,NAMELY, MEDICAL STIMULATION DEVICES HAVING A LASER AND/OR SEMICONDUCTOR DIODES FOR EMITTING LIGHT RADIATION TO ACTIVATE LIGHT-ACTIVATABLE SUBSTANCES ABSORBED INTO TISSUE AND AN ELECTROMAGNETIC WAVE RADIATOR FOR CONCURRENTLY EMITTING ELECTROMAGNETIC RADIATION ONTO THE TISSUE
No 78186213
No Service/Collective Mark
No 5089-4
No
No
No
No
No
No
No
No
26.11.21 -
Rectangles that are completely or partially shaded
| Status Date | Action Taken |
|---|---|
| 25th Mar 2005 | ASSIGNED TO EXAMINER |
| 25th Mar 2005 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL |
| 21st Mar 2005 | ASSIGNED TO EXAMINER |
| 17th Mar 2005 | EXPARTE APPEAL TERMINATED |
| 08th Mar 2005 | ASSIGNED TO EXAMINER |
| 07th Mar 2005 | ASSIGNED TO EXAMINER |
| 04th Dec 2004 | ABANDONMENT - AFTER EX PARTE APPEAL |
| 04th Dec 2004 | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF |
| 18th Aug 2004 | PAPER RECEIVED |
| 18th Aug 2004 | EX PARTE APPEAL-INSTITUTED |
